Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery.


OBJECTIVE The use of recombinant factor VIIa (rFVIIa) (NovoSeven RT(®)) to establish hemostasis during massive perioperative bleeding in cardiac surgery has been explored in several retrospective studies. While early results are promising, a paucity of data leaves many questions about its safety profile. We sought to further define its use and associated… (More)
DOI: 10.1016/j.ejcts.2011.03.048

Cite this paper

@article{Chapman2011RecombinantFV, title={Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery.}, author={Alistair J Chapman and Andrew L. Blount and Alan T. Davis and Robert L Hooker}, journal={European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery}, year={2011}, volume={40 6}, pages={1314-8; discussion 1318-9} }